PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CVS vs. SCHD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between CVS and SCHD is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

CVS vs. SCHD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CVS Health Corporation (CVS) and Schwab US Dividend Equity ETF (SCHD). The values are adjusted to include any dividend payments, if applicable.

100.00%200.00%300.00%400.00%NovemberDecember2025FebruaryMarchApril
177.38%
362.87%
CVS
SCHD

Key characteristics

Sharpe Ratio

CVS:

0.05

SCHD:

0.06

Sortino Ratio

CVS:

0.37

SCHD:

0.19

Omega Ratio

CVS:

1.05

SCHD:

1.03

Calmar Ratio

CVS:

0.04

SCHD:

0.05

Martin Ratio

CVS:

0.13

SCHD:

0.23

Ulcer Index

CVS:

16.56%

SCHD:

3.79%

Daily Std Dev

CVS:

40.95%

SCHD:

15.78%

Max Drawdown

CVS:

-64.07%

SCHD:

-33.37%

Current Drawdown

CVS:

-30.52%

SCHD:

-12.75%

Returns By Period

In the year-to-date period, CVS achieves a 56.81% return, which is significantly higher than SCHD's -6.56% return. Over the past 10 years, CVS has underperformed SCHD with an annualized return of -1.05%, while SCHD has yielded a comparatively higher 10.23% annualized return.


CVS

YTD

56.81%

1M

7.20%

6M

6.83%

1Y

4.21%

5Y*

6.12%

10Y*

-1.05%

SCHD

YTD

-6.56%

1M

-6.97%

6M

-9.72%

1Y

1.14%

5Y*

13.17%

10Y*

10.23%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CVS vs. SCHD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CVS
The Risk-Adjusted Performance Rank of CVS is 6060
Overall Rank
The Sharpe Ratio Rank of CVS is 6262
Sharpe Ratio Rank
The Sortino Ratio Rank of CVS is 5656
Sortino Ratio Rank
The Omega Ratio Rank of CVS is 5757
Omega Ratio Rank
The Calmar Ratio Rank of CVS is 6262
Calmar Ratio Rank
The Martin Ratio Rank of CVS is 6161
Martin Ratio Rank

SCHD
The Risk-Adjusted Performance Rank of SCHD is 5151
Overall Rank
The Sharpe Ratio Rank of SCHD is 5151
Sharpe Ratio Rank
The Sortino Ratio Rank of SCHD is 5050
Sortino Ratio Rank
The Omega Ratio Rank of SCHD is 5050
Omega Ratio Rank
The Calmar Ratio Rank of SCHD is 5252
Calmar Ratio Rank
The Martin Ratio Rank of SCHD is 5252
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CVS vs. SCHD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for CVS Health Corporation (CVS) and Schwab US Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CVS, currently valued at 0.05, compared to the broader market-2.00-1.000.001.002.00
CVS: 0.05
SCHD: 0.06
The chart of Sortino ratio for CVS, currently valued at 0.37, compared to the broader market-4.00-2.000.002.004.00
CVS: 0.37
SCHD: 0.19
The chart of Omega ratio for CVS, currently valued at 1.05, compared to the broader market0.501.001.502.00
CVS: 1.05
SCHD: 1.03
The chart of Calmar ratio for CVS, currently valued at 0.04, compared to the broader market0.001.002.003.004.00
CVS: 0.04
SCHD: 0.05
The chart of Martin ratio for CVS, currently valued at 0.13, compared to the broader market-5.000.005.0010.0015.0020.00
CVS: 0.13
SCHD: 0.23

The current CVS Sharpe Ratio is 0.05, which is comparable to the SCHD Sharpe Ratio of 0.06. The chart below compares the historical Sharpe Ratios of CVS and SCHD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.05
0.06
CVS
SCHD

Dividends

CVS vs. SCHD - Dividend Comparison

CVS's dividend yield for the trailing twelve months is around 3.83%, less than SCHD's 4.11% yield.


TTM20242023202220212020201920182017201620152014
CVS
CVS Health Corporation
3.83%5.93%3.06%2.36%1.94%2.93%2.69%3.05%2.76%2.15%1.43%1.14%
SCHD
Schwab US Dividend Equity ETF
4.11%3.64%3.49%3.39%2.78%3.16%2.98%3.06%2.63%2.89%2.97%2.63%

Drawdowns

CVS vs. SCHD - Drawdown Comparison

The maximum CVS drawdown since its inception was -64.07%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for CVS and SCHD. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-30.52%
-12.75%
CVS
SCHD

Volatility

CVS vs. SCHD - Volatility Comparison

The current volatility for CVS Health Corporation (CVS) is 10.31%, while Schwab US Dividend Equity ETF (SCHD) has a volatility of 11.03%. This indicates that CVS experiences smaller price fluctuations and is considered to be less risky than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%NovemberDecember2025FebruaryMarchApril
10.31%
11.03%
CVS
SCHD
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab